Perspectives on Pain
From early-stage research to clinical practice, four experts offer their take on the potential of cannabis-based pain relief
Jonathan James | | Longer Read
If you conducted a straw poll on the medical indications of cannabis, pain would likely be at the top of the list. With a relatively solid safety profile, legalization advocates claim that cannabis-based treatments may be a magic bullet for the chronic pain that plagues as many as 1 in 5 Americans – and thus one answer to the country’s deadly opioid epidemic. Notably, an estimated 67 percent of US cannabis prescriptions are already for chronic pain relief (1).
But beyond the anecdotes and hyperbole, there is mixed evidence for the efficacy of cannabinoids in the treatment of pain (2, 3) – perhaps unsurprising given the huge range of causes and types of pain. We spoke with four experts working across the spectrum of pain research to get a clearer idea of the state of the field – from biologists shedding light on the role of the endocannabinoid system in pain and inflammation, through to doctors running (tightly-regulated) clinical trials and assessing the impact on their patients.
Read the full article now
Log in or register to read this article in full and gain access to The Cannabis Scientist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Cannabis Scientist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.